Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers

NCT03935893 is registered in ClinicalTrials.gov with Udai Kammula as lead sponsor.

NCT NCT03935893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03935893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers
Lead sponsor
Udai Kammula
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 3, 2019
Completion date
June 30, 2038
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, gastric cancer, merkel cell carcinoma, mesothelioma, microsatellite instability, mismatch repair deficiency, neuroendocrine tumors, pancreatic cancer, sarcoma, squamous cell cancer